Skip to search formSkip to main contentSkip to account menu

DTTX30

Known as: DTTX-30 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

ChlorobenzenesPyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
EFFECTS OF THE COMBINED THROMBOXANE RECEPTOR ANTAGONIST AND SYNTHASE INHIBITOR DTTX‐30 ON INTESTINAL O2‐EXCHANGE AND ENERGY METABOLISM DURING HYPERDYNAMIC PORCINE ENDOTOXEMIA
ABSTRACT Sepsis may lead to deranged thromboxane‐prostacyclin ratio with consecutive organ dysfunction. Because of the suggested… 
1997
1997
DTTX30, a combined thromboxane receptor antagonist and thromboxane synthetase inhibitor, prevents coronary thrombosis in anesthetized dogs
BackgroundCombined thromboxane A2 receptor blockade and thromboxane synthetase inhibition facilitates local prostacyclin… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)